CJC-1295 with DAC is a synthetic growth hormone-releasing hormone (GHRH) analog that has attracted scientific interest for its interactions with growth hormone signaling pathways and endocrine regulation. The addition of Drug Affinity Complex (DAC) technology has been studied for its ability to extend the activity profile of the peptide within laboratory models.

Research involving CJC-1295 with DAC has explored growth hormone secretion, pituitary signaling, endocrine function, metabolic processes, and hormone-related biological pathways. Scientists continue to investigate how long-acting GHRH analogs influence physiological signaling and peptide-receptor interactions in controlled research environments.

CJC-1295 with DAC remains an active area of investigation in studies focused on hormone regulation, metabolic biology, and endocrine research.

Blackburn Peptides supplies CJC-1295 with DAC as a research-grade material intended exclusively for laboratory and scientific applications.

This product is not intended for human or veterinary use.